FDA Will Reverse Rejection of Third Rare-Disease Drug, Regenxbio Says
The company plans to refile its application for its gene therapy for a fatal brain disease after the FDA dropped demands to give a placebo to some study subjects.
Connecting Global Economies
Flash News
Argentina vs Austria live updates: World Cup 2026 game latest news with Messi poised to start
AbbVie to Buy Apogee Therapeutics for $10.9 Billion in Cash
UK PM Starmer resigns as Britain faces its seventh leader in 10 years
The World Cup in Las Vegas: Pool parties, star-spangled dungarees and 480 cans of Tennent’s
FDA Will Reverse Rejection of Third Rare-Disease Drug, Regenxbio Says
KNDS IPO moves closer after France-Germany deal
How Turkey’s World Cup hopes fell apart – and rendered USMNT clash a dead rubber
SpaceX stock drops again after rally following blockbuster IPO
Poll: Americans draw a new line in the betting bonanza sweeping over Wall Street — politics.
How Lamine Yamal won his race for World Cup fitness to score ‘most important’ goal
Monday, June 22, 2026